BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35925305)

  • 21. [Current best practices and biobanking recomedations.].
    Doludin YV; Borisova AL; Pokrovskaya MS; Stefanyuk OV; Sivakova OV; Botsoeva SA; Meshkov AN; Metelskaya VA; Drapkina OM
    Klin Lab Diagn; 2019; 64(12):769-776. PubMed ID: 32040903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proof-of-Concept Integration of Heterogeneous Biobank IT Infrastructures into a Hybrid Biobanking Network.
    Mate S; Kadioglu D; Majeed RW; Stöhr MR; Folz M; Vormstein P; Storf H; Brucker DP; Keune D; Zerbe N; Hummel M; Senghas K; Prokosch HU; Lablans M
    Stud Health Technol Inform; 2017; 243():100-104. PubMed ID: 28883179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Canadian Tissue Repository Network Biobank Certification and the College of American Pathologists Biorepository Accreditation Programs: Two Strategies for Knowledge Dissemination in Biobanking.
    Barnes RO; Shea KE; Watson PH
    Biopreserv Biobank; 2017 Feb; 15(1):9-16. PubMed ID: 27740852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Man's best friend in life and death: scientific perspectives and challenges of dog brain banking.
    Sándor S; Czeibert K; Salamon A; Kubinyi E
    Geroscience; 2021 Aug; 43(4):1653-1668. PubMed ID: 33970413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality-Assured Biobanking: The Leiden University Medical Center Model.
    Haumann R; Verspaget HW
    Methods Mol Biol; 2018; 1730():361-370. PubMed ID: 29363088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of Indicators in the Context of Biobanking.
    Slušná ĽK; Balog M
    Biopreserv Biobank; 2023 Aug; 21(4):318-326. PubMed ID: 36099204
    [No Abstract]   [Full Text] [Related]  

  • 27. [Biobanking and the further development of precision medicine].
    Dahl E
    Pathologe; 2018 Jul; 39(4):308-312. PubMed ID: 29876651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The EuPA Biobank Initiative: Meeting the future challenges of biobanking in proteomics & systems medicine.
    Wheelock ÅM; Paulson L; Litton JE;
    J Proteomics; 2015 Sep; 127(Pt B):414-6. PubMed ID: 26216594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Setting up indicators in biobanking: why and how?].
    Hofman V; Gaziello MC; Bonnetaud C; Ilie M; Mauro V; Long E; Selva E; Gavric-Tanga V; Lassalle S; Butori C; Papin-Michaud C; Lerda N; Bordone O; Coelle C; Sabourin JC; Chabannon C; Hofman P
    Ann Pathol; 2012 Apr; 32(2):91-101. PubMed ID: 22520599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biobanks collected for routine healthcare purposes: build-up and use for epidemiologic research.
    Dillner J; Andersson K
    Methods Mol Biol; 2011; 675():113-25. PubMed ID: 20949385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges for quality management in implementation, maintenance, and sustainability of research tissue biobanks.
    Schmitt S; Kynast K; Schirmacher P; Herpel E
    Virchows Arch; 2016 Jan; 468(1):93-9. PubMed ID: 26271995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management.
    Bonizzi G; Capra M; Cassi C; Taliento G; Pala O; Sajjadi E; Venetis K; Ivanova M; Monturano M; Renne G; Zattoni L; Guerini-Rocco E; Viale G; Orecchia R; Fusco N
    J Vis Exp; 2022 Nov; (189):. PubMed ID: 36533819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population-Based Biobanking.
    Lieb W; Strathmann EA; Röder C; Jacobs G; Gaede KI; Richter G; Illig T; Krawczak M
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nordic biological specimen bank cohorts as basis for studies of cancer causes and control: quality control tools for study cohorts with more than two million sample donors and 130,000 prospective cancers.
    Pukkala E
    Methods Mol Biol; 2011; 675():61-112. PubMed ID: 20949384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality management of biorepositories.
    Grizzle WE; Gunter EW; Sexton KC; Bell WC
    Biopreserv Biobank; 2015 Jun; 13(3):183-94. PubMed ID: 26035008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biobanks as the basis for developing biomedicine: Problems and prospects].
    Reznik ON; Kuzmin DO; Reznik AO
    Mol Biol (Mosk); 2017; 51(5):761-771. PubMed ID: 29116062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organization of BBMRI.pl: The Polish Biobanking Network.
    Witoń M; Strapagiel D; Gleńska-Olender J; Chróścicka A; Ferdyn K; Skokowski J; Kalinowski L; Pawlikowski J; Marciniak B; Pasterk M; Matera-Witkiewicz A; Kozera Ł
    Biopreserv Biobank; 2017 Jun; 15(3):264-269. PubMed ID: 28103080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The landscape of biobanks in Poland-characteristics of Polish biobanking units at the beginning of BBMRI.pl organization.
    Chróścicka A; Paluch A; Kozera Ł; Lewandowska-Szumieł M
    J Transl Med; 2021 Jun; 19(1):267. PubMed ID: 34158056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tissue bank of the National Centre for Tumour Disease. An innovative platform for translational tumour].
    Herpel E; Koleganova N; Schirmacher P
    Pathologe; 2008 Nov; 29 Suppl 2():204-9. PubMed ID: 18836724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Securing the sustainability of biobanks].
    Kirsten R; Hummel M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):390-5. PubMed ID: 26769112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.